EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance

Gokce Akan iD, Ismael Chatita Adolf, Adil Colak, Seda Acar, Fatih Oncu, Dogan Yesilbursa, Solmaz Turkcan, Fatmahan Atalar, Sema Bilgic Gazioglu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70694 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Gokce Akan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, MUHAS Genetics Laboratory, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: Schizophrenia, Polymorphism, Single Nucleotide, Iodide Peroxidase, Thyroid Hormones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid hormone modulates multiple neurotransmitter systems, including dopaminergic, serotonergic, glutamatergic and GABAergic pathways, which are implicated in schizophrenia (SCH) pathophysiology. The Type II deiodinase (DIO2) enzyme plays a critical role in thyroid metabolism, converting thyroxine (T4) into the biologically active triiodothyronine (T3). This study aimed to investigate the potential association between DIO2 gene polymorphisms, Thr92Ala and ORFa‐Gly3Asp, with serum levels of free triiodothyronine (fT3), free thyroxine (fT4) and thyroid‐stimulating hormone (TSH) in SCH susceptibility and symptomatology. The cohort included 582 unrelated patients diagnosed with SCH and 603 healthy controls. Genotyping of Thr92Ala and ORFa‐Gly3Asp single nucleotide polymorphisms (SNPs) of the DIO2 gene was conducted along with serum measurements of TSH, fT4 and fT3 levels. The genotype distribution of Thr92Ala and ORFa‐Gly3Asp genotypes differed significantly between SCH group and the controls ( p < 0.001). Furthermore, patients with SCH exhibited significantly lower levels of fT3 ( p < 0.001) and TSH ( p < 0.001) compared with controls. Notably, the Thr92Ala genotypes displayed a significant association with altered fT3 and TSH levels in SCH patients ( p < 0.05, respectively). This study identified a significant association between DIO2 polymorphisms and decreased levels of fT3 and TSH in Turkish patients with SCH. Given the impact of thyroid hormones on neurotransmitter systems involved in SCH, these results highlight the potential for thyroid hormone modulation as a therapeutic avenue. Further research could lead to more personalised treatment strategies, particularly for patients with genetic predispositions to altered thyroid hormone metabolism, improving clinical outcomes and offering new approaches to managing symptoms in schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaPolymorphism, Single NucleotideIodide PeroxidaseThyroid HormonesNeurosecretory SystemsHumansIodothyronine Deiodinase Type IIFemaleMaleAdultGenetic Predisposition to DiseaseMiddle AgedCase-Control StudiesGenotypeThyrotropinTriiodothyronineThyroxine

Stichwörter der Autor:innen

DIO2case‐control studydeiodinase enzyme IIgenotypingpolymorphismschizophreniathyroid hormone

Substanzen

Iodothyronine Deiodinase Type IIIodide PeroxidaseThyroid HormonesThyrotropinTriiodothyronineThyroxine

Autor:innen und Institutionen

  • Biochemistry Department, MUHAS Genetics Laboratory, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • DESAM Research Institute, Near East University, Mersin 10, Türkiye.
  • Department of Biomedical Engineering, Biomedical Engineering Institute, Bogazici University, Istanbul, Türkiye.
  • Department of Bioengineering, Yildiz Technical University, Istanbul, Türkiye.
  • Psychiatry Clinics, Turkish Ministry of Health Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery, Istanbul, Türkiye.
  • Rare Diseases Research Laboratory, Istanbul Medical Faculty, Istanbul University, Istanbul, Türkiye.

ORCID-Profile: Gokce Akan

Zitieren

APA

Akan, G., Adolf, I. C., Colak, A., Acar, S., Oncu, F., Yesilbursa, D., Turkcan, S., Atalar, F., & Gazioglu, S. B. (2025). Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70694

Vancouver

Akan G, Adolf IC, Colak A, Acar S, Oncu F, Yesilbursa D, et al. Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70694

BibTeX
@article{Akan2025,
  author = {Akan, Gokce and Adolf, Ismael Chatita and Colak, Adil and Acar, Seda and Oncu, Fatih and Yesilbursa, Dogan and Turkcan, Solmaz and Atalar, Fatmahan and Gazioglu, Sema Bilgic},
  title = {Thyroid Hormone Dynamics and DIO2 Variants in Schizophrenia: Exploring Genetic Links to Neuroendocrine Imbalance},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70694}
}
Kostenlos starten →